DGAP-News

B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN on growth track in the first half-year 2016/17

DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG / Key word(s): Half Year Results B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN on growth track in the first half-year 2016/17 31.05.2017 / 08:30 The issuer is solely responsible for the content of this announcement. BRAIN on growth track in the first half-year 2016/17

• Revenue up 9% to EUR 12.1 million
• 
  
• Increase of total operating performance from EUR 13.0 million to EUR 13.3 million
• 
  
• BioScience segment grows 8%
• 
  
• BioIndustrial segment with positive EBIT contribution
• 
  
• Operating cash flow improved significantly
• 
  

Zwingenberg, May 31, 2017: B.R.A.I.N. Biotechnology Research and Information Network AG ("BRAIN AG"; ISIN DE0005203947 / WKN 520394) today published its financial results for the first half of fiscal year 2016/17. Accordingly, during the reporting period from October 1, 2016, to March 31, 2017, the BRAIN Group grew its total operating performance by 3 percent from EUR 13.0 million to EUR 13.3 million. This development was driven mainly by the strong growth of the BioScience segment in the second quarter. At the same time, revenues of BRAIN Group increased by 9 percent from EUR 11.2 million to EUR 12.1 million. The half-year EBIT was down from EUR -5.3 million to EUR -5.6 million mostly due to first quarter special items with no impact on liquidity. The BioIndustrial segment generated a positive EBIT contribution of EUR 0.2 million. The operating cash flow developed positively, amounting to EUR -2.3 million compared to EUR -4.6 million in the previous year period.